HB 4423 requires the Oklahoma Health Care Authority to verify the immigration status of all Medicaid applicants using the federal SAVE system (or its successor) before approving benefits. It specifically mandates that the Authority notify U.S. Immigration and Customs Enforcement (ICE) if an applicant's status cannot be verified as lawful. This applies to all applicants, including adults applying for child-only Medicaid benefits on behalf of a child. The bill takes effect October 1, 2026, and does not change Medicaid eligibility criteria but adds a verification step for immigration status.
SB 1425 repeals three existing Oklahoma statutes related to health care workforce programs: 70 O.S. 2021 §2640 (Oklahoma Health Care Workers and Educators Assistance Program) and 74 O.S. 2021 §§3200.1-3200.2 (Health Care Workforce Resources Act). This bill eliminates the legal framework for these specific programs, which previously provided assistance to health care workers and educators. The repeal takes effect on November 1, 2026, and directly affects the administrative structure and operations of those programs. No new provisions or funding are created; the bill solely removes the existing laws.
HB 3644 (the Blake Burgess Act) requires hospitals with emergency departments and ambulatory surgical centers to implement standardized VTE (venous thromboembolism, or blood clot in veins) risk assessments for patients using nationally recognized tools and provide annual training to non-physician clinical staff. It mandates a statewide VTE registry managed by a private, nonprofit entity meeting specific criteria, which hospitals must report to starting July 2027 with data including patient age, zip code, sex, diagnosis details, and treatment. The registry collects information to improve VTE care quality, monitor outcomes, and inform state health reports, with hospitals required to submit data on VTE incidence, patient demographics, and treatment. The law directly affects hospitals, ambulatory surgical centers, and their clinical staff through new screening, training, and reporting obligations.
HB 3834, the "Oklahoma Breakthrough Therapy Act," establishes a framework for ibogaine clinical trials in Oklahoma. It requires drug developers to match state funding for trials, provide detailed plans for FDA approval and post-approval patient access (including priority for state residents and low-income care), and share intellectual property proceeds with the state. These proceeds fund an "Ibogaine Intellectual Property Account" managed by the State Treasurer, which must be spent on programs for at-risk populations with conditions treatable by ibogaine (like opioid use disorder). The bill also protects Oklahoma-licensed medical professionals from adverse licensing actions for recommending ibogaine therapy.
HB 3767 adds specific synthetic drugs and substances to Oklahoma's Schedule I and IV of controlled dangerous substances under state law. It directly affects anyone possessing, distributing, or using the newly listed compounds, including various fentanyl analogs (like para-fluorofentanyl), synthetic hallucinogens (like psilocybin and salvia), and other novel psychoactive substances. The bill amends Oklahoma's Controlled Dangerous Substances Act by expanding the official lists in Schedule I (substances with no medical use and high abuse potential) and Schedule IV (substances with accepted medical use but potential for abuse). This creates new legal prohibitions for these substances without requiring additional medical or legal exceptions.
HB 2268 requires the Oklahoma Medicaid Program or its contracted entities to reimburse providers for "cognitive assessment and care planning services" (defined using standard medical billing code 99483). This directly affects low-income Medicaid beneficiaries who receive these specific cognitive care services. The bill mandates reimbursement for these services under existing Medicaid rules, with no new funding or eligibility changes. It takes effect November 1, 2025.
SB 1428 creates the Office of Alzheimer’s Disease and Related Dementia Service Coordination within Oklahoma’s State Department of Health, effective November 1, 2026. The office will coordinate statewide dementia services, eliminate duplicated efforts, collect data, support staff training, and identify grant opportunities to improve care for individuals with Alzheimer’s or related dementias and their caregivers. It requires the office to maintain a full-time dementia services coordinator position to manage operations. The bill repeals two outdated sections of Oklahoma law (63 O.S. 2021, Sections 1-879.2 and 1-879.3) related to dementia services.
HB 3143 extends Oklahoma's moratorium on new medical marijuana business licenses (dispensaries, processors, growers) from August 1, 2026, to August 1, 2028. It requires existing license holders to get written approval from the Oklahoma Medical Marijuana Authority before transferring ownership, including submitting documentation to the Oklahoma State Bureau of Narcotics. Transfers must follow a 15-business-day timeline for license and registration changes, and applicants cannot submit transfer requests if disciplinary actions are pending. The bill also mandates that businesses provide a full inventory of all medical marijuana products during ownership changes and prohibits transfers without approval, with a 30-day window for pending applications to comply with new rules.
SB 1847 modifies Oklahoma's ADvantage Waiver Program, which provides Medicaid home- and community-based services. It creates an exception allowing individuals with cognitive impairments to qualify if they were already residing in an assisted living center contracted with the state when their impairment developed, and the center has a specific accommodation plan. This change directly affects adults with cognitive impairments who live in state-contracted assisted living facilities and developed their condition after moving in. The bill does not alter financial or age requirements but adjusts eligibility for this specific group. The exception applies to those meeting all three conditions outlined in the bill's new subsection B.
HB 3194 protects Oklahoma pregnancy centers from state mandates requiring them to provide abortion services, contraception, or referrals. The bill prohibits state agencies from forcing centers to offer abortion-inducing drugs, post promotional materials for abortion, restrict services based on their pro-life stance, or interfere with their staffing decisions. It also allows centers to sue for triple damages (minimum $10,000) if state agencies violate these provisions. The law directly affects pregnancy centers - both general and medical - and state agencies that might attempt to impose such requirements. It focuses on preventing government compulsion, not restricting abortion access.
